Final answer:
CK should be monitored vigorously if a patient is on statins to identify muscle damage early and prevent complications. Hence the statement is true
Step-by-step explanation:
True, CK should be monitored vigorously if a patient is on statins. CK, or creatine kinase, is an enzyme found in the muscles and when the muscle fibers are damaged, this enzyme is released into the bloodstream. Statins are a class of medications used to lower cholesterol levels, but they can sometimes cause muscle damage as a side effect. Monitoring CK levels can help identify muscle damage early and prevent serious complications.
Hence the statement is true